diagnostics

Roche transforms mass spectrometry diagnostics with launch of cobas Mass Spec solution

December 18, 2024 01:00 ET  | Source: F. Hoffmann-La Roche Ltd Roche launches its cobas® Mass Spec solution, bringing mass…

6 days ago

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

New oligonucleotide facility is designed to support "Make in India" initiative by synthesizing Co-Primers® in-house. Attendees of new ribbon-cutting event…

2 weeks ago

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

New oligonucleotide facility is designed to support "Make in India" initiative by synthesizing Co-Primers® in-house. Attendees of new ribbon-cutting event…

2 weeks ago

LearnEV+ and CarTechIQ Launch GlobalTechIQ to Transform Heavy-Duty Diagnostics with AI

WYLIE, Texas and LEXINGTON, Ky., Nov. 22, 2024 (GLOBE NEWSWIRE) -- LearnEV+ and CarTechIQ have joined forces to launch GlobalTechIQ,…

1 month ago

Approx. USD 4.0 M Invested in Product Development for NTDs – GHIT’s First Investment in the Development of Diagnostics for Trachoma

TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

1 month ago

Approx. USD 4.0 M Invested in Product Development for NTDs – GHIT’s First Investment in the Development of Diagnostics for Trachoma

TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

1 month ago

Approx. USD 4.0 M Invested in Product Development for NTDs – GHIT’s First Investment in the Development of Diagnostics for Trachoma

TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

2 months ago

Approx. USD 4.0 M Invested in Product Development for NTDs – GHIT’s First Investment in the Development of Diagnostics for Trachoma

TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

2 months ago

Approx. USD 4.0 M Invested in Product Development for NTDs – GHIT’s First Investment in the Development of Diagnostics for Trachoma

TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

2 months ago

RapidAI Applauded by Frost & Sullivan for Enhancing the Quality, Accuracy, and Speed of Stroke Imaging Diagnostics and Treatment, Demonstrating Its Market-leading Position

RapidAI's leadership is evident in its expansive global presence, pioneering regulatory achievements, and continuous innovation, ensuring the company remains at…

2 months ago